by admin | Jul 12, 2021 | Press Release
Seattle, WA, July 15, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the future expansion of its biologics manufacturing capabilities through a lease agreement to occupy a...
by admin | Jun 16, 2021 | News
Today Lumen announced a new collaboration with Novo Nordisk to explore new treatments for cardiometabolic diseases. We couldn’t be more thrilled. Cardiometabolic disease — a cluster of related conditions that includes obesity, diabetes, and cardiovascular disease —...